Vaccine

• Euvichol^®
• Euvichol^®-Plus
• Euvichol^®-S
• EuCorVac-19^™

EuCorVac-19^™ Inj. Multi-dose

EuCorVac-19^™ is a subunit vaccine (recombinant protein vaccine) that minimizes unnecessary antibody formation by including only the RBD antigen of the ACE2 receptor binding domain spike protein, which has the advantage of having only antigenic components that can effectively induce immune function, resulting in fewer side effects. In addition, to induce sufficient immunogenicity, EcML^™ can be used as an adjuvant to promote humoral and cellular immune responses through TLR4 receptor stimulation, and by directly linking the antigen to liposomes using CoPoP and presenting the antigen on the liposome surface, more antigen can be provided to dendritic cells than general liposome-based vaccines to maximize antigen formation. Based on our experience in developing the EuCorVac-19^™ , under developing vaccines against variants.

Product Name	EuCorVac-19™ Inj. Multi-dose (SARS-CoV-2 Spike Protein Vaccine(Recombinant))
Product Purpose	Prescription Medicine (Export only)
Administration	Intramuscularly, 2 doses at 4 weeks apart
Appearance	Injection filled in a colorless and transparent vial with a light green, transparent liquid.
Efficacy / Effectiveness	Active immunization for the prevention of coronavirus disease 2019(COVID-19) caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) in individuals 18 years of age and older